Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese Participants
Sponsor: Boehringer Ingelheim
Summary
To assess pharmacokinetics, safety, and tolerability of multiple oral doses of verducatib in healthy Chinese male and female trial participants in order to facilitate the clinical development of verducatib in China.
Official title: Pharmacokinetics, Safety, and Tolerability Study of Multiple Oral Doses of Verducatib for 4 Weeks in Healthy Chinese Male and Female Trial Participants (Open-label, Single Arm)
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2026-07-13
Completion Date
2026-10-14
Last Updated
2026-04-15
Healthy Volunteers
Yes
Conditions
Interventions
Verducatib
Verducatib
Locations (1)
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, China